Overview

Antibiotics Study in Preterm Premature Rupture of the Membranes

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy on maternal infection, chorioamnionitis and neonatal morbidity and mortality, and to review the evidence and provide recommendations on the use of antibiotics in PPROM.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefazolin
Clarithromycin
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate